公司资料
GE HealthCare Technologies Inc. 股价、新闻与催化剂
- 股票代码:
- GEHC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
72.37 USD (-1.79%)
收盘价
最后更新: 2026年8月17日
28.2B USD
市值
股价为何变动
As of Aug 17, 2026, GEHC closed down 1.79% at $72.37. No new same-company headline was identified in the current news window.
公司概览
业务概览
GE HealthCare is a global healthcare technology company focused on imaging, ultrasound, monitoring, and related clinical workflow solutions. The company supports diagnosis and care delivery rather than developing therapeutic drugs.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, GE HealthCare has a global footprint across hospitals and diagnostic centers. It belongs to medical technology and healthcare equipment rather than biotechnology.
商业模式特征
The business generates revenue through equipment, consumables, service contracts, and enterprise healthcare solutions. Investors focus on equipment demand, installed base performance, service growth, and global healthcare spending.
生物医药行业定位
GE HealthCare sits outside biotech and closer to the diagnostic and imaging infrastructure layer. It matters to healthcare investors because diagnostic spending and capital budgets can influence the broader life-sciences ecosystem.
未来催化剂
- GE HealthCare’s catalysts are imaging and ultrasound product cycles, AI-enabled workflow adoption, and the next round of product or clearance updates. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
- 01
- 02
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。